echemi logo
Product
  • Product
  • Supplier
  • Inquiry

    plus 41

    Learn all about plus 41. Discover things that you didn't know about plus 41 on echemi.com.
    • First-line treatment for pancreatic cancer! CD73 inhibitor AB680 plus chemotherapy and anti-PD-1

      Time of Update: 2021-01-27
      (results detailed in: ARC-8: Phase 1/1b Study to Evaluate Safety and Tolerability of AB680 , Between and Zimberelimab (AB122) in Patients Treatment with-Naive Metastatic Pancreatic Adenocarcinoma AB68 0 (Photo source: tsbiochem.com) AB680 is an ultra-powerful, selective small molecule CD73 inhibitor designed to provide benefits different from monoclonal antibodies, such as stronger inhibition of CD73 enzyme activity (soluble and cell-binding) and deeper tumor penetration.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.